Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kusaba

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Oncogene|September 6, 2018
Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancerMichitaka Nakano, Yoshikane Kikushige, Kohta Miyawaki, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2015
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapyKenta Nio, Shuji Arita, Taichi Isobe, et al.
Cancer Science|November 17, 2010
Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Kitaro Futami, et al.
Japanese Journal of Clinical Oncology|February 11, 2004
Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancerHirokazu Watanabe, Noboru Yamamoto, Tomohide Tamura, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancerKyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2022
Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeonsNobu Akiyama, Takuho Okamura, Minoru Yoshida, et al.
Cancer Science|August 2, 2018
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibodyKyoko Yamaguchi, Koji Mishima, Hirofumi Ohmura, et al.
Case Reports in Oncology|September 10, 2014
Successful chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary arteryHozumi Kumagai, Kenta Nio, Yuta Okumura, et al.
International Journal of Clinical Oncology|January 4, 2019
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancerTomoyasu Yoshihiro, Hitoshi Kusaba, Akitaka Makiyama, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Oncogene|September 6, 2018
Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancerMichitaka Nakano, Yoshikane Kikushige, Kohta Miyawaki, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2015
Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapyKenta Nio, Shuji Arita, Taichi Isobe, et al.
Cancer Science|November 17, 2010
Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancerHitoshi Kusaba, Taito Esaki, Kitaro Futami, et al.
Japanese Journal of Clinical Oncology|February 11, 2004
Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancerHirokazu Watanabe, Noboru Yamamoto, Tomohide Tamura, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancerKyoko Yamaguchi, Hitoshi Kusaba, Akitaka Makiyama, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2022
Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeonsNobu Akiyama, Takuho Okamura, Minoru Yoshida, et al.
Cancer Science|August 2, 2018
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibodyKyoko Yamaguchi, Koji Mishima, Hirofumi Ohmura, et al.
Case Reports in Oncology|September 10, 2014
Successful chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary arteryHozumi Kumagai, Kenta Nio, Yuta Okumura, et al.
International Journal of Clinical Oncology|January 4, 2019
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancerTomoyasu Yoshihiro, Hitoshi Kusaba, Akitaka Makiyama, et al.
Medicine|September 9, 2020
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III studyAyumu Hosokawa, Kentaro Yamazaki, Chu Matsuda, et al.
Pageof 11